Originally published 2022-01-13.
On 7 January 2022, surgeons at the University of Maryland Medical Center in Baltimore replaced the failing heart of David Bennett Sr., a 57-year-old Maryland man, with the heart of a genetically modified pig. It was the first time a pig heart had been transplanted into a living person. Bennett survived the operation and lived for two months with the new heart before he died on 8 March 2022. His case did not produce a lasting cure, but it opened a new chapter in xenotransplantation, the transplanting of animal organs into humans, and led directly to the pig-heart and pig-kidney operations that followed.
Above, left: Bennett in his hospital bed with surgeon Bartley Griffith a few days after the operation. Right: members of the surgical team prepare the pig heart before implanting it. Both photos were released by the University of Maryland School of Medicine.
Who David Bennett was and why he got a pig heart
Bennett had terminal heart disease. By late 2021 he was bedridden and kept alive by ECMO, a machine that pumps and oxygenates blood outside the body. His doctors judged that he was not eligible for a conventional human heart transplant, and he had no other treatment options left. He agreed to try the experimental procedure, reportedly telling his doctors that it was either that or die.
Because no clinical trial for pig hearts existed, the US Food and Drug Administration granted emergency authorisation on 31 December 2021 under its compassionate-use rules, which allow experimental treatments for patients with life-threatening conditions and no alternatives. The operation, led by Dr Bartley Griffith with Dr Muhammad Mohiuddin, the scientific director of the university's cardiac xenotransplantation programme, took place a week later and lasted around seven hours, according to BBC reporting.
How the pig heart was engineered
A normal pig heart would be destroyed by the human immune system within minutes. Human bodies carry antibodies against certain sugar molecules on pig cells, and they launch what doctors call hyperacute rejection. To prevent this, the donor pig was bred by Revivicor, a subsidiary of United Therapeutics, with ten genetic modifications:
- pig genes that produce the sugars responsible for hyperacute rejection were switched off;
- a pig growth-hormone gene was disabled so the heart would not keep growing once inside a human chest;
- several human genes were added to help the organ avoid immune attack, blood clotting and inflammation.
Even with these changes, Bennett needed stronger immune-suppressing treatment than a standard transplant patient, including an experimental antibody drug. Dr Christine Lau, chair of surgery at the University of Maryland School of Medicine, explained the uncertainty to the BBC at the time, saying no one really knew how he would do because the procedure had never been done before.
What happened after the operation
For several weeks the heart worked well, with no sign of rejection. He was able to spend time with his family, and his doctors reported encouraging early progress. Then, in early March, his condition began to deteriorate and he died on 8 March 2022. His son, David Bennett Jr., thanked the medical teams and said the family hoped the story could be "the beginning of hope and not the end."
Researchers later reported that the pig heart had carried a pig virus, porcine cytomegalovirus, which screening had missed. Whether the virus caused the heart to fail is not certain; other factors, including Bennett's very weak condition before surgery and the antibody treatments he received, may have played a part.
Why doctors want animal organs at all
The motivation is simple arithmetic. According to the US Health Resources and Services Administration, about 110,000 people in the United States were on the national transplant waiting list in 2026, another person is added every seven minutes, and around 12 people die each day waiting for an organ. More than 49,000 transplants were performed in 2025, which is a record but still far short of the need. (Estimates quoted in 2022 put the daily death toll at about 17.)
Dr Lau put the hope plainly: "People die all the time on the waiting list, waiting for organs." If genetically engineered pigs could supply organs on demand, she added, transplant teams would no longer need to fly around the country at night to collect donated organs.
Pig tissue is not new to medicine. Replacement heart valves made from pig or cow tissue have been used for decades, but their cells are chemically treated and no longer alive, so they are not true xenotransplants. Earlier attempts with whole animal hearts ended quickly: a chimpanzee heart transplanted by James Hardy in 1964 failed within two hours, and the infant known as Baby Fae lived 21 days with a baboon heart in 1984. In the months before Bennett's surgery, a team at NYU Langone had attached a pig kidney to a brain-dead patient to see whether it would be rejected.
The pig-organ transplants that followed
Bennett's operation was the start of a fast-moving series of experiments:
- 2022: NYU Langone transplanted pig hearts with the same ten gene edits into two recently deceased people to study how they behaved.
- September 2023: the Maryland team gave a second pig heart to Lawrence Faucette, 58. He showed signs of rejection and died on 30 October 2023, about six weeks after surgery.
- March 2024: Massachusetts General Hospital transplanted a pig kidney with 69 genetic edits, made by eGenesis, into Richard Slayman. He died a few months later of causes doctors said were unrelated, with no apparent rejection.
- 2024: Lisa Pisano received a pig kidney together with a heart pump; the kidney was removed after problems with blood flow.
- 2024–2025: Towana Looney of Alabama lived with a gene-edited pig kidney for 130 days before it was removed after rejection.
- 2025: Tim Andrews lived 271 days with a pig kidney, roughly doubling the previous record, before rejection led to its removal in October 2025. He received a human kidney in January 2026.
- 2025: the FDA approved a formal clinical trial by eGenesis of gene-edited pig kidneys in 30 dialysis patients aged 50 and over.
Kidneys have moved ahead of hearts partly because patients can return to dialysis if a pig kidney fails, which makes the experiments less risky than replacing a heart.
The ethical debate
Not everyone welcomes the research. Animal-welfare groups object to breeding pigs specifically as organ donors, and some ethicists worry about the risk of animal viruses crossing into humans, as the virus found in Bennett's heart showed is possible. Others point out that Bennett and the early kidney patients were extremely ill, so their short survival tells us less than a trial in healthier patients would. Supporters answer that pigs are already raised and killed in huge numbers for food, and that thousands of people die every year for lack of an organ.
What is clear is that the January 2022 operation changed the question from "could a pig heart ever work in a person?" to "how long can it work, and for whom?" The answer is still being written in operating rooms and clinical trials.
Sources: University of Maryland School of Medicine: In memoriam, David Bennett Sr.; Wikipedia: Xenotransplantation; HRSA, organdonor.gov: Organ donation statistics. Photos: University of Maryland School of Medicine. Original report: BBC News, January 2022.

COMMENTS